A citation-based method for searching scientific literature

M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
Times Cited: 2129







List of co-cited articles
578 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
651
39

Validation studies for models projecting the risk of invasive and total breast cancer incidence.
J P Costantino, M H Gail, D Pee, S Anderson, C K Redmond, J Benichou, H S Wieand. J Natl Cancer Inst 1999
490
24

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
Debbie Saslow, Carla Boetes, Wylie Burke, Steven Harms, Martin O Leach, Constance D Lehman, Elizabeth Morris, Etta Pisano, Mitchell Schnall, Stephen Sener,[...]. CA Cancer J Clin 2007
18

Projecting individualized absolute invasive breast cancer risk in African American women.
Mitchell H Gail, Joseph P Costantino, David Pee, Melissa Bondy, Lisa Newman, Mano Selvan, Garnet L Anderson, Kathleen E Malone, Polly A Marchbanks, Worta McCaskill-Stevens,[...]. J Natl Cancer Inst 2007
186
15

Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model.
Jeffrey A Tice, Steven R Cummings, Rebecca Smith-Bindman, Laura Ichikawa, William E Barlow, Karla Kerlikowske. Ann Intern Med 2008
331
13

Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort.
Adam R Brentnall, Elaine F Harkness, Susan M Astley, Louise S Donnelly, Paula Stavrinos, Sarah Sampson, Lynne Fox, Jamie C Sergeant, Michelle N Harvie, Mary Wilson,[...]. Breast Cancer Res 2015
99
13

BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors.
Andrew Lee, Nasim Mavaddat, Amber N Wilcox, Alex P Cunningham, Tim Carver, Simon Hartley, Chantal Babb de Villiers, Angel Izquierdo, Jacques Simard, Marjanka K Schmidt,[...]. Genet Med 2019
125
13

The BOADICEA model of genetic susceptibility to breast and ovarian cancer.
A C Antoniou, P P D Pharoah, P Smith, D F Easton. Br J Cancer 2004
282
12


Prediction of breast cancer risk based on profiling with common genetic variants.
Nasim Mavaddat, Paul D P Pharoah, Kyriaki Michailidou, Jonathan Tyrer, Mark N Brook, Manjeet K Bolla, Qin Wang, Joe Dennis, Alison M Dunning, Mitul Shah,[...]. J Natl Cancer Inst 2015
302
12

Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women.
Rayna K Matsuno, Joseph P Costantino, Regina G Ziegler, Garnet L Anderson, Huilin Li, David Pee, Mitchell H Gail. J Natl Cancer Inst 2011
91
10

Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis.
Valerie A McCormack, Isabel dos Santos Silva. Cancer Epidemiol Biomarkers Prev 2006
10

Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention.
B Rockhill, D Spiegelman, C Byrne, D J Hunter, G A Colditz. J Natl Cancer Inst 2001
414
9

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
B Fisher, J P Costantino, D L Wickerham, C K Redmond, M Kavanah, W M Cronin, V Vogel, A Robidoux, N Dimitrov, J Atkins,[...]. J Natl Cancer Inst 1998
9

Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density.
Jinbo Chen, David Pee, Rajeev Ayyagari, Barry Graubard, Catherine Schairer, Celia Byrne, Jacques Benichou, Mitchell H Gail. J Natl Cancer Inst 2006
237
9

10-year performance of four models of breast cancer risk: a validation study.
Mary Beth Terry, Yuyan Liao, Alice S Whittemore, Nicole Leoce, Richard Buchsbaum, Nur Zeinomar, Gillian S Dite, Wendy K Chung, Julia A Knight, Melissa C Southey,[...]. Lancet Oncol 2019
52
17

A Deep Learning Mammography-based Model for Improved Breast Cancer Risk Prediction.
Adam Yala, Constance Lehman, Tal Schuster, Tally Portnoi, Regina Barzilay. Radiology 2019
93
9

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.
A C Antoniou, A P Cunningham, J Peto, D G Evans, F Lalloo, S A Narod, H A Risch, J E Eyfjord, J L Hopper, M C Southey,[...]. Br J Cancer 2008
300
8

Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme.
E Amir, D G Evans, A Shenton, F Lalloo, A Moran, C Boggis, M Wilson, A Howell. J Med Genet 2003
181
8

Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.
Adam R Brentnall, Jack Cuzick, Diana S M Buist, Erin J Aiello Bowles. JAMA Oncol 2018
73
10

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.
Nasim Mavaddat, Kyriaki Michailidou, Joe Dennis, Michael Lush, Laura Fachal, Andrew Lee, Jonathan P Tyrer, Ting-Huei Chen, Qin Wang, Manjeet K Bolla,[...]. Am J Hum Genet 2019
243
8

A systematic review and quality assessment of individualised breast cancer risk prediction models.
Javier Louro, Margarita Posso, Michele Hilton Boon, Marta Román, Laia Domingo, Xavier Castells, María Sala. Br J Cancer 2019
30
26

Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement.
Douglas K Owens, Karina W Davidson, Alex H Krist, Michael J Barry, Michael Cabana, Aaron B Caughey, Chyke A Doubeni, John W Epling, Martha Kubik, C Seth Landefeld,[...]. JAMA 2019
42
19



Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.
Kevin C Oeffinger, Elizabeth T H Fontham, Ruth Etzioni, Abbe Herzig, James S Michaelson, Ya-Chen Tina Shih, Louise C Walter, Timothy R Church, Christopher R Flowers, Samuel J LaMonte,[...]. JAMA 2015
708
7

Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.
D A Berry, G Parmigiani, J Sanchez, J Schildkraut, E Winer. J Natl Cancer Inst 1997
253
7

Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States.
Paige Maas, Myrto Barrdahl, Amit D Joshi, Paul L Auer, Mia M Gaudet, Roger L Milne, Fredrick R Schumacher, William F Anderson, David Check, Subham Chattopadhyay,[...]. JAMA Oncol 2016
145
7


Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
Douglas K Owens, Karina W Davidson, Alex H Krist, Michael J Barry, Michael Cabana, Aaron B Caughey, Chyke A Doubeni, John W Epling, Martha Kubik, C Seth Landefeld,[...]. JAMA 2019
110
7

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
7

Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.
Ruth M Pfeiffer, Yikyung Park, Aimée R Kreimer, James V Lacey, David Pee, Robert T Greenlee, Saundra S Buys, Albert Hollenbeck, Bernard Rosner, Mitchell H Gail,[...]. PLoS Med 2013
90
6

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
Donald A Berry, Edwin S Iversen, Daniel F Gudbjartsson, Elaine H Hiller, Judy E Garber, Beth N Peshkin, Caryn Lerman, Patrice Watson, Henry T Lynch, Susan G Hilsenbeck,[...]. J Clin Oncol 2002
326
6


Benign breast disease and the risk of breast cancer.
Lynn C Hartmann, Thomas A Sellers, Marlene H Frost, Wilma L Lingle, Amy C Degnim, Karthik Ghosh, Robert A Vierkant, Shaun D Maloney, V Shane Pankratz, David W Hillman,[...]. N Engl J Med 2005
497
6

Mammographic density and the risk and detection of breast cancer.
Norman F Boyd, Helen Guo, Lisa J Martin, Limei Sun, Jennifer Stone, Eve Fishell, Roberta A Jong, Greg Hislop, Anna Chiarelli, Salomon Minkin,[...]. N Engl J Med 2007
6

Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2019
6


Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR.
Debra L Monticciolo, Mary S Newell, Linda Moy, Bethany Niell, Barbara Monsees, Edward A Sickles. J Am Coll Radiol 2018
188
6

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.
Victor G Vogel, Joseph P Costantino, D Lawrence Wickerham, Walter M Cronin, Reena S Cecchini, James N Atkins, Therese B Bevers, Louis Fehrenbacher, Eduardo R Pajon, James L Wade,[...]. JAMA 2006
6

Comparison of a Deep Learning Risk Score and Standard Mammographic Density Score for Breast Cancer Risk Prediction.
Karin Dembrower, Yue Liu, Hossein Azizpour, Martin Eklund, Kevin Smith, Peter Lindholm, Fredrik Strand. Radiology 2020
23
26

Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer.
Jeffrey A Tice, Diana L Miglioretti, Chin-Shang Li, Celine M Vachon, Charlotte C Gard, Karla Kerlikowske. J Clin Oncol 2015
101
6

Breast cancer risk assessment and management in primary care: provider attitudes, practices, and barriers.
Susan A Sabatino, Ellen P McCarthy, Russell S Phillips, Risa B Burns. Cancer Detect Prev 2007
73
6

Patterns of breast magnetic resonance imaging use in community practice.
Karen J Wernli, Wendy B DeMartini, Laura Ichikawa, Constance D Lehman, Tracy Onega, Karla Kerlikowske, Louise M Henderson, Berta M Geller, Mike Hofmann, Bonnie C Yankaskas. JAMA Intern Med 2014
93
5

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.
M H Gail, J P Costantino, J Bryant, R Croyle, L Freedman, K Helzlsouer, V Vogel. J Natl Cancer Inst 1999
465
5

Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications.
Jessica A Cintolo-Gonzalez, Danielle Braun, Amanda L Blackford, Emanuele Mazzola, Ahmet Acar, Jennifer K Plichta, Molly Griffin, Kevin S Hughes. Breast Cancer Res Treat 2017
68
7

Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry.
Gillian S Dite, Robert J MacInnis, Adrian Bickerstaffe, James G Dowty, Richard Allman, Carmel Apicella, Roger L Milne, Helen Tsimiklis, Kelly-Anne Phillips, Graham G Giles,[...]. Cancer Epidemiol Biomarkers Prev 2016
62
8

Genetic analysis of breast cancer in the cancer and steroid hormone study.
E B Claus, N Risch, W D Thompson. Am J Hum Genet 1991
748
5

Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia.
Judy C Boughey, Lynn C Hartmann, Stephanie S Anderson, Amy C Degnim, Robert A Vierkant, Carol A Reynolds, Marlene H Frost, V Shane Pankratz. J Clin Oncol 2010
70
7

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial.
Jack Cuzick, Ivana Sestak, John F Forbes, Mitch Dowsett, Jill Knox, Simon Cawthorn, Christobel Saunders, Nicola Roche, Robert E Mansel, Gunter von Minckwitz,[...]. Lancet 2014
337
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.